Discussing quality-of-life issues with a patient newly diagnosed with prostate cancer.
A 66-year-old man with hypertension, hyperlipidemia, and benign prostatic hyperplasia presented for evaluation of an elevated PSA level of 6.2 ng/ml. Transrectal ultrasound-guided 12-core prostate needle biopsy. Clinically localized, clinical stage T1c adenocarcinoma of the prostate. Following a full discussion of the risks and benefits of his treatment options, including quality-of-life sequelae, the patient opted for radical prostatectomy.